DDReg pharma

Quailty Driven by Passion

Submit Query

Blogs

Home » Blogs » Page 2
Global Cosmetic Regulations A Guide for Cometic Products

Understanding Global Cosmetic Regulatory Standards

Blogs, Regulatory /

The global cosmetic industry is a complex and rapidly growing landscape where regulatory compliance is fundamental in ensuring product safety, efficacy, and market access. As cosmetic products cross borders, manufacturers must comply with country-specific regulations from ingredients safety to product labeling. These regulations protect consumers and set the standards that businesses must follow to enter […]

Understanding Global Cosmetic Regulatory Standards Read More »

Outsourcing MAH

How Does Outsourcing MAH Responsibilities Impact a Pharmaceutical Company’s Global Expansion Strategy?

Blogs /

Marketing Authorisation Holder (MAH) refers to a person or company that has been granted permission to market a pharmaceutical product within a specific country. MAHs are subject to a number of regulatory requirements and ensure pharmaceutical products meet stringent safety and quality standards. As regulatory frameworks are becoming more stringent, many companies are turning to

How Does Outsourcing MAH Responsibilities Impact a Pharmaceutical Company’s Global Expansion Strategy? Read More »

Digital Revolution on Pharmaceutical Industry

Impact of the Digital Revolution on Pharmaceutical Industry

Blogs, Regulatory /

The pharmaceutical industry, long characterized by traditional research and manufacturing practices, is currently undergoing a profound revolution. Led by advanced analytics, artificial intelligence (AI), blockchain, and other cutting-edge technologies, digital innovations are revolutionizing drug discovery, manufacturing, marketing patient care services and regulatory oversight, with real world examples and extensive research supporting these changes. This blog

Impact of the Digital Revolution on Pharmaceutical Industry Read More »

Veterinary Regulations

Navigating Challenges and Future Opportunities in Veterinary Regulations

Blogs, Regulatory /

The field of veterinary medicine is rapidly advancing, driven by new therapies and technologies as well as increasing public health concerns about antimicrobial resistance (AMR). Regulatory agencies around the world–such as FDA, EMA and regional bodies–are adapting quickly to these changes, with regulatory frameworks constantly adapting to ensure veterinary medicinal products (VMPs) meet stringent safety

Navigating Challenges and Future Opportunities in Veterinary Regulations Read More »

Malaysia Pharmaceutical Regulatory Pathway

Understanding the Pharmaceutical Regulatory Landscape of Malaysia

Blogs, Regulatory /

Malaysia’s pharmaceutical industry is a rapidly growing sector, driven by increasing healthcare demands, advancements in medical research, and government support. For pharmaceutical companies looking to enter the Malaysian market, understanding the regulatory framework is crucial. The National Pharmaceutical Regulatory Agency (NPRA) plays a key role in overseeing drug approvals, quality standards, and compliance with national

Understanding the Pharmaceutical Regulatory Landscape of Malaysia Read More »

Registered Products in USA through Pharma Regulatory Consultant

How Pharmaceutical Regulatory Consultant Helps Product Registration in the USA

Blogs, Regulatory /

The pharmaceutical regulatory consultants are specialists in FDA regulations and can guide companies through the registration process for their products making sure that all the required documentation, clinical data, and measures to ensure compliance are in the correct order. Over the decades, the regulatory framework in the United States has advanced and driven by scientific

How Pharmaceutical Regulatory Consultant Helps Product Registration in the USA Read More »

PRIME vs. EU pathways: Strategy, global impact, and drug development insights

Comparing PRIME and EU Pathways: Long -Term Strategy and Global Impact

Blogs, Regulatory /

In the European Union (EU), the European Medicines Agency (EMA) has implemented several expedited regulatory pathways, notably the PRIority MEdicines (PRIME) scheme, to facilitate the development and approval of promising medicines. Launched in March 2016, the PRIME scheme aims to enhance support for the development of medicines that target an unmet medical need. In addition

Comparing PRIME and EU Pathways: Long -Term Strategy and Global Impact Read More »

impact of vitro diagnostic medical device regulation in EU

Understanding the Impact of IVDR on Precision Medicine Development in the EU

Blogs, Regulatory /

The European Union introduced the In Vitro Diagnostic Regulation (IVDR), an elaborate regulatory framework intended to increase safety, performance and reliability of in vitro diagnostic (IVD) medical devices. Replacing its predecessor (IVDD), EU IVDR requires stricter requirements for compliance while placing greater emphasis on clinical evidence, risk classification and post market surveillance. Precision medicine, an innovative

Understanding the Impact of IVDR on Precision Medicine Development in the EU Read More »

Current Trends patient engagement in healthcare

Patient Engagement in Healthcare: Current Trends and Future Opportunities

Blogs, Clinical Regulatory, Medical Writing, Pharmacovigilance, Regulatory /

For years, the focus of healthcare development and delivery has been on treatment and outcomes, often with limited input from patients. However, there is now a growing recognition that patients should not just be passive recipients of care—they should be active participants in their own healthcare journey. This patient-centered approach is transforming the way drugs

Patient Engagement in Healthcare: Current Trends and Future Opportunities Read More »

Collaborating for Global Success in Advanced Therapy Medicinal Products (ATMPs)

Blogs, Regulatory, Uncategorized /

Advanced Therapy Medicinal Products (ATMPs) are transforming the medical landscape, offering revolutionary treatments for diseases that previously lacked effective solutions. These products include cutting-edge innovations such as gene therapies, somatic cell therapies, and tissue-engineered products. Despite their potential, ATMPs face numerous challenges—scientific, regulatory, logistical, and financial—that hinder their development and global market access. Addressing these

Collaborating for Global Success in Advanced Therapy Medicinal Products (ATMPs) Read More »